Anika Therapeutics, Inc. (ANIK)
Nasdaq: ANIK · CIK 0000898437 · United States
Every official Anika Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ANIK filings
Anika Therapeutics, Inc. documents
- Anika Therapeutics, Inc. 10-K 2026ANIK 10-K 2026: annual report for fiscal 2026
- Anika Therapeutics, Inc. 10-K 2025ANIK 10-K 2025: annual report for fiscal 2025
- Anika Therapeutics, Inc. 10-K 2024ANIK 10-K 2024: annual report for fiscal 2024
- Anika Therapeutics, Inc. 10-K 2023ANIK 10-K 2023: annual report for fiscal 2023
- Anika Therapeutics, Inc. 10-K 2022ANIK 10-K 2022: annual report for fiscal 2022
- Anika Therapeutics, Inc. 10-Q 2026ANIK 10-Q 2026: quarterly report for fiscal 2026
- Anika Therapeutics, Inc. 10-Q 2025ANIK 10-Q 2025: quarterly report for fiscal 2025
- Anika Therapeutics, Inc. 10-Q 2024ANIK 10-Q 2024: quarterly report for fiscal 2024
- Anika Therapeutics, Inc. 10-Q 2023ANIK 10-Q 2023: quarterly report for fiscal 2023
- Anika Therapeutics, Inc. 10-Q 2022ANIK 10-Q 2022: quarterly report for fiscal 2022
- Anika Therapeutics, Inc. 8-K 2026ANIK 8-K 2026: current report for fiscal 2026
- Anika Therapeutics, Inc. 8-K 2025ANIK 8-K 2025: current report for fiscal 2025
- Anika Therapeutics, Inc. 8-K 2024ANIK 8-K 2024: current report for fiscal 2024
- Anika Therapeutics, Inc. 8-K 2023ANIK 8-K 2023: current report for fiscal 2023
- Anika Therapeutics, Inc. 8-K 2022ANIK 8-K 2022: current report for fiscal 2022
- Anika Therapeutics, Inc. DEF 14A 2026ANIK DEF 14A 2026: proxy statement for fiscal 2026
- Anika Therapeutics, Inc. DEF 14A 2025ANIK DEF 14A 2025: proxy statement for fiscal 2025
- Anika Therapeutics, Inc. DEF 14A 2024ANIK DEF 14A 2024: proxy statement for fiscal 2024
- Anika Therapeutics, Inc. DEF 14A 2023ANIK DEF 14A 2023: proxy statement for fiscal 2023
- Anika Therapeutics, Inc. DEF 14A 2022ANIK DEF 14A 2022: proxy statement for fiscal 2022
- Anika Therapeutics, Inc. Form 4 2026ANIK Form 4 2026: insider trading filing for fiscal 2026
- Anika Therapeutics, Inc. Form 4 2025ANIK Form 4 2025: insider trading filing for fiscal 2025
- Anika Therapeutics, Inc. Form 4 2024ANIK Form 4 2024: insider trading filing for fiscal 2024
- Anika Therapeutics, Inc. Form 4 2023ANIK Form 4 2023: insider trading filing for fiscal 2023
- Anika Therapeutics, Inc. Form 4 2022ANIK Form 4 2022: insider trading filing for fiscal 2022
- Anika Therapeutics, Inc. S-1 2026ANIK S-1 2026: registration statement for fiscal 2026
- Anika Therapeutics, Inc. S-1 2025ANIK S-1 2025: registration statement for fiscal 2025
- Anika Therapeutics, Inc. S-1 2024ANIK S-1 2024: registration statement for fiscal 2024
- Anika Therapeutics, Inc. S-1 2023ANIK S-1 2023: registration statement for fiscal 2023
- Anika Therapeutics, Inc. S-1 2022ANIK S-1 2022: registration statement for fiscal 2022
- Anika Therapeutics, Inc. 13F 2026ANIK 13F 2026: institutional holdings for fiscal 2026
- Anika Therapeutics, Inc. 13F 2025ANIK 13F 2025: institutional holdings for fiscal 2025
- Anika Therapeutics, Inc. 13F 2024ANIK 13F 2024: institutional holdings for fiscal 2024
- Anika Therapeutics, Inc. 13F 2023ANIK 13F 2023: institutional holdings for fiscal 2023
- Anika Therapeutics, Inc. 13F 2022ANIK 13F 2022: institutional holdings for fiscal 2022
More companies